Compare MetLife Inc. Common Stock (MET) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MetLife Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? MetLife Inc. Common Stock trades at $98.97 (market cap $60.87B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: MetLife Inc. Common Stock is far larger — about 15.4× Relay Therapeutics Inc. Common Stock's market cap, and MetLife Inc. Common Stock pays a 2.47% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MetLife Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| MET | RLAY | |
|---|---|---|
Market Cap | $60.87B | $3.94B |
Volume | 3,175,937 | 3,432,928 |
Sector | Financials | Health |
52-Week High | $99.95 | $20.75 |
52-Week Low | $67.70 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $81.79B | $3.06B |
Dividend Yield | 2.47% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MetLife Inc. Common Stock
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
